GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

PAVM · Dec 31, 2023

PAVmed Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]

Inspectable configuration

State dimensions

Filing0001493152-24-011172General Corporate

Capex intensityRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.capex_revenue_ratio

9.87% · OPTIONAL · NOT_ENOUGH_HISTORY

Operating cash generationRAWCurrent state valid · history insufficient

Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

-2122.19% · OPTIONAL · NOT_ENOUGH_HISTORY

Revenue growthRAWCurrent state valid · history insufficient

Evidence method

Yoy · gp.fundamentals.revenue

550.40% · CORE · NOT_ENOUGH_HISTORY

Inventory pressureRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

11.34% · OPTIONAL · NOT_ENOUGH_HISTORY

Operating marginRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.operating_margin

-2805.67% · CORE · NOT_ENOUGH_HISTORY

R&D intensityRAWCurrent state valid · history insufficient

Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

582.22% · OPTIONAL · NOT_ENOUGH_HISTORY

SBC intensityRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

454.28% · OPTIONAL · NOT_ENOUGH_HISTORY

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History12 statesHistory building

Sep 30, 20230/6 normalizedLevel 3 Dec 31, 20230/7 normalizedLevel 3 Mar 31, 20240/8 normalizedLevel 3 Jun 30, 20240/8 normalizedLevel 3 Sep 30, 20245/8 normalizedLevel 3 Dec 31, 20245/6 normalizedLevel 3 Mar 31, 20255/6 normalizedLevel 3 Jun 30, 20255/6 normalizedLevel 3 Sep 30, 20256/6 normalizedLevel 3 Dec 31, 20256/6 normalizedLevel 3 Mar 31, 20266/6 normalizedLevel 3 Jun 30, 20266/6 normalizedLevel 3

Period transition

What moved in the state?

Capex Intensity Increased

Previous: 2.28%
Current: 9.87%
Delta: 7.59%

Cash Generation Decreased

Previous: -1401.90%
Current: -2122.19%
Delta: -720.29%

Growth Decreased

Previous: 940.79%
Current: 550.40%
Delta: -390.39%

Profitability Decreased

Previous: -1963.08%
Current: -2805.67%
Delta: -842.58%

R And D Intensity Increased

Previous: 399.62%
Current: 582.22%
Delta: 182.60%

Sbc Intensity Increased

Previous: 283.82%
Current: 454.28%
Delta: 170.46%

Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.

Research Graph

Related governed research

Transitioned To · PAVM Fundamental State →Transitioned To · PAVM Fundamental State →Transitioned To · PAVM CAPEX_INTENSITY_INCREASED →Transitioned To · PAVM CASH_GENERATION_DECREASED →Transitioned To · PAVM GROWTH_DECREASED →Transitioned To · PAVM PROFITABILITY_DECREASED →Transitioned To · PAVM R_AND_D_INTENSITY_INCREASED →Transitioned To · PAVM SBC_INTENSITY_INCREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.